City Insurance PLC. (DSE:CITYGENINS)
Bangladesh
· Delayed Price · Currency is BDT 57.20
+0.80 (1.42%)
At close: Aug 14, 2025
City Insurance PLC. Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 646.99 | 583.93 | 516.49 | 567.91 | 483.41 | 328.37 | Upgrade
|
| Total Interest & Dividend Income | 112.47 | 118.54 | 94.09 | 66.77 | 63.58 | 47.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | 23.62 | 23.62 | 4.42 | 13.28 | 14.41 | 41.26 | Upgrade
|
| Other Revenue | 87.71 | 84.45 | 58.94 | 66.87 | 55.15 | 23.41 | Upgrade
|
| Total Revenue | 870.79 | 810.54 | 673.93 | 714.83 | 616.54 | 440.32 | Upgrade
|
| Revenue Growth (YoY) | 16.06% | 20.27% | -5.72% | 15.94% | 40.02% | 15.71% | Upgrade
|
| Policy Benefits | 143.39 | 102.59 | 19.54 | 91.08 | 179.64 | 48.52 | Upgrade
|
| Policy Acquisition & Underwriting Costs | 152.96 | 154.74 | 121.19 | 161.72 | 55.37 | 63.26 | Upgrade
|
| Depreciation & Amortization | 4.98 | 4.98 | 7.89 | 6.61 | 7.19 | 5.61 | Upgrade
|
| Selling, General & Administrative | 268.02 | 250.16 | 222.2 | 241.33 | 208.62 | 158.08 | Upgrade
|
| Total Operating Expenses | 569.34 | 512.47 | 370.81 | 500.74 | 450.81 | 275.47 | Upgrade
|
| Operating Income | 301.45 | 298.08 | 303.12 | 214.09 | 165.73 | 164.85 | Upgrade
|
| Interest Expense | - | - | - | - | -1.22 | -0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.5 | -2.5 | -1.69 | -1.39 | -0.87 | -1.41 | Upgrade
|
| EBT Excluding Unusual Items | 298.95 | 295.58 | 301.44 | 212.7 | 163.63 | 163.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.53 | 0.53 | -0.01 | 0.91 | - | 0.05 | Upgrade
|
| Asset Writedown | -1 | -1 | -1 | -1 | -1.02 | -1 | Upgrade
|
| Pretax Income | 298.48 | 295.11 | 300.42 | 212.61 | 162.61 | 162.06 | Upgrade
|
| Income Tax Expense | 96.54 | 85.43 | 94.79 | 59.03 | 47.89 | 41.31 | Upgrade
|
| Net Income | 201.94 | 209.68 | 205.64 | 153.58 | 114.72 | 120.75 | Upgrade
|
| Net Income to Common | 201.94 | 209.68 | 205.64 | 153.58 | 114.72 | 120.75 | Upgrade
|
| Net Income Growth | -12.92% | 1.97% | 33.90% | 33.88% | -4.99% | 76.16% | Upgrade
|
| Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 68 | 68 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 68 | 68 | Upgrade
|
| Shares Change (YoY) | 0.06% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 2.97 | 3.08 | 3.02 | 2.25 | 1.68 | 1.77 | Upgrade
|
| EPS (Diluted) | 2.97 | 3.08 | 3.02 | 2.25 | 1.68 | 1.77 | Upgrade
|
| EPS Growth | -12.97% | 1.97% | 33.90% | 33.88% | -4.99% | 76.16% | Upgrade
|
| Free Cash Flow | 203.21 | 165.02 | 169.02 | 370.87 | 167.32 | 106.92 | Upgrade
|
| Free Cash Flow Per Share | 2.98 | 2.42 | 2.48 | 5.44 | 2.46 | 1.57 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 1.200 | 1.050 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | -16.67% | -16.67% | 14.29% | 5.00% | - | 100.00% | Upgrade
|
| Operating Margin | 34.62% | 36.78% | 44.98% | 29.95% | 26.88% | 37.44% | Upgrade
|
| Profit Margin | 23.19% | 25.87% | 30.51% | 21.49% | 18.61% | 27.42% | Upgrade
|
| Free Cash Flow Margin | 23.34% | 20.36% | 25.08% | 51.88% | 27.14% | 24.28% | Upgrade
|
| EBITDA | 304.62 | 302.74 | 310.74 | 220.47 | 172.63 | 170.45 | Upgrade
|
| EBITDA Margin | 34.98% | 37.35% | 46.11% | 30.84% | 28.00% | 38.71% | Upgrade
|
| D&A For EBITDA | 3.18 | 4.66 | 7.62 | 6.38 | 6.9 | 5.61 | Upgrade
|
| EBIT | 301.45 | 298.08 | 303.12 | 214.09 | 165.73 | 164.85 | Upgrade
|
| EBIT Margin | 34.62% | 36.78% | 44.98% | 29.95% | 26.88% | 37.44% | Upgrade
|
| Effective Tax Rate | 32.34% | 28.95% | 31.55% | 27.76% | 29.45% | 25.49% | Upgrade
|
Updated Nov 3, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.